Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02386826
Title INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors SCRI Development Innovations, LLC
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Sarah Cannon Research Institute at HealthONE Denver Colorado 80218 United States Details
Yale School of Medicine New Haven Connecticut 06520 United States Details
HCA Midwest - Kansas City Kansas City Missouri 64132 United States Details
Oklahoma University Health Science Center Oklahoma City Oklahoma 73104 United States Details
Tennessee Oncology PLLC Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from for the field